Topics

Sihuan Pharma Plans to Bring Anti-Infective Generics from India's Hetero Lab to China

02:08 EST 13 Feb 2020 | ChinaBio Today

Sihuan Pharma and Hetero Labs, an Indian generic drug maker, have signed a framework cooperation agreement to bring Hetero's products -- including potential COVID-19 anti-infectives -- to China. Hetero claims to be the leading producer of anti-retroviral drugs for HIV/AIDS, serving 40% of the HIV/AIDS population globally with 30 anti-retroviral product combinations. Sihuan, a novel drug company, will make and distribute Hetero's generic products in China. More details....

Stock Symbol: (HKEX: 0460)

Share this with colleagues:

Original Article: Sihuan Pharma Plans to Bring Anti-Infective Generics from India's Hetero Lab to China

NEXT ARTICLE

More From BioPortfolio on "Sihuan Pharma Plans to Bring Anti-Infective Generics from India's Hetero Lab to China"

Quick Search

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...